Thus, all facilities that perform procedures requiring the use of EPINEPHrine 1 mg/mL (1:1000) for topical application should review their processes and consider the following recommendations.

The product was also found to be misbranded with a misleading label and is similar in appearance to the FDA-approved drug product Adrenalin® (epinephrine injection, USP) (1mg/mL) 30mL vial ...

Bupivacaine HCl 2.5mg/mL, 5mg/mL; epinephrine 1:200000; soln for inj. Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical ...

is “misbranded with a misleading label similar in appearance to the FDA-approved drug product Adrenalin® (epinephrine injection, USP) (1mg/mL) 30mL vial … The similarity in labeling makes it ...

Lidocaine HCl 5mg/mL with epinephrine 1:200000, 10mg/mL with epinephrine 1:100000, 20mg/mL with epinephrine 1:100000; soln; contains methylparaben, sodium metabisulfite. See full labeling for ...

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill., December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that ...

Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.

Information gathered after the event indicated that the syringe contained EPINEPHrine 1 mg/mL (1:1,000) intended for topical use. You may recall a similar event that occurred more than a decade ...

is now available in the United States as the first generic version of Epinephrine in a 1mg/1mL vial for U.S. customers. This press release features multimedia. View the full release here ...

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill., December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that ...